Clinical trial
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With…
NCT00207714 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00207714 |
|---|---|
| Title | An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis |
| Official title | A Randomized, Double-blind, Dose-ranging Trial of CNTO 148 Subcutaneous Injection Compared With Placebo in Subjects With Active Rheumatoid Arthritis Despite Treatment With Methotrexate |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Centocor BV Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Golimumab, MTX, Placebo, Infliximab |
| Enrollment | 172 |
| Start date | Nov 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 18, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: